Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age
- 15 December 2000
- Vol. 89 (12) , 2667-2676
- https://doi.org/10.1002/1097-0142(20001215)89:12<2667::aid-cncr21>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the NetherlandsAnnals of Oncology, 1998
- Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.Journal of Clinical Oncology, 1998
- CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.Journal of Clinical Oncology, 1998
- Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.Journal of Clinical Oncology, 1997
- Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimenAnnals of Oncology, 1996
- Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.Journal of Clinical Oncology, 1995
- Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1995
- P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL)Annals of Oncology, 1994
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993